Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency

Clinical trial NCT01563926 · COMPLETED

Trial details

NCT number: NCT01563926
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Growth Hormone Disorder Growth Hormone Deficiency in Children Genetic Disorder Turner Syndrome

Start date: 2000-10-23
Primary completion: 2002-10-10
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.